GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
02 06 2020
Historique:
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 13 4 2021
Statut: epublish

Résumé

Mucormycosis, caused by

Identifiants

pubmed: 32487760
pii: mBio.01087-20
doi: 10.1128/mBio.01087-20
pmc: PMC7267888
pii:
doi:

Substances chimiques

Endoplasmic Reticulum Chaperone BiP 0
HSPA5 protein, human 0
Heat-Shock Proteins 0
Hspa5 protein, mouse 0
Receptors, Vitronectin 0
integrin alphavbeta1 0
ErbB Receptors EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI124566
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI063503
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI110820
Pays : United States
Organisme : NIAID NIH HHS
ID : R43 AI138904
Pays : United States
Organisme : NIDCR NIH HHS
ID : R00 DE026856
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD097480
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI141360
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI141794
Pays : United States

Informations de copyright

Copyright © 2020 Alqarihi et al.

Références

N Engl J Med. 2012 Dec 6;367(23):2214-25
pubmed: 23215557
Clin Infect Dis. 2012 Feb;54 Suppl 1:S16-22
pubmed: 22247441
mBio. 2018 Aug 14;9(4):
pubmed: 30108171
Clin Infect Dis. 2004 Aug 15;39(4):588-90
pubmed: 15356828
Nat Rev Cancer. 2014 Apr;14(4):263-76
pubmed: 24658275
Otolaryngol Clin North Am. 2000 Apr;33(2):349-65
pubmed: 10736409
Curr Opin Infect Dis. 2013 Dec;26(6):508-15
pubmed: 24126718
Lancet. 2005 Mar 5-11;365(9462):876-8
pubmed: 15752532
Electrophoresis. 1999 Apr-May;20(4-5):1001-10
pubmed: 10344278
J Clin Invest. 2014 Jan;124(1):237-50
pubmed: 24355926
Nat Microbiol. 2016 Nov 14;2:16211
pubmed: 27841851
Clin Microbiol Rev. 2005 Jul;18(3):556-69
pubmed: 16020690
Clin Microbiol Rev. 2000 Apr;13(2):236-301
pubmed: 10756000
J Infect Dis. 2008 Oct 1;198(7):1083-90
pubmed: 18694335
Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):215-29
pubmed: 16568297
Clin Infect Dis. 2000 Jun;30(6):851-6
pubmed: 10852735
J Bronchology Interv Pulmonol. 2015 Oct;22(4):338-42
pubmed: 26348693
Leuk Lymphoma. 2004 Jul;45(7):1351-60
pubmed: 15359632
Clin Microbiol Infect. 2015 Jun;21(6):594.e1-5
pubmed: 25726039
Pathol Res Pract. 2007;203(10):705-15
pubmed: 17804177
J Clin Microbiol. 2008 Nov;46(11):3690-702
pubmed: 18845827
J Antimicrob Chemother. 2012 Mar;67(3):715-22
pubmed: 21937481
J Clin Invest. 2010 Jun;120(6):1914-24
pubmed: 20484814
J Cell Biol. 1996 Jan;132(1-2):227-38
pubmed: 8567726
Antimicrob Agents Chemother. 2013 Jul;57(7):3340-7
pubmed: 23650163
J Clin Invest. 2016 Jun 1;126(6):2280-94
pubmed: 27159390
Infect Immun. 1995 Nov;63(11):4368-74
pubmed: 7591072
Cell. 1990 Mar 9;60(5):861-71
pubmed: 2311122
J Membr Biol. 2004 Aug 1;200(3):115-32
pubmed: 15625821
mSphere. 2018 May 2;3(3):
pubmed: 29720523
Sci Adv. 2019 Jun 12;5(6):eaaw1327
pubmed: 31206021
Nat Commun. 2016 Jul 22;7:12218
pubmed: 27447865
Cell. 2002 Sep 20;110(6):673-87
pubmed: 12297042
Mol Genet Genomics. 2004 May;271(4):499-510
pubmed: 15067540
J Trauma. 1992 Jan;32(1):12-5
pubmed: 1732565
Clin Microbiol Infect. 2019 Jan;25(1):26-34
pubmed: 30036666
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Clin Microbiol Infect. 2016 Sep;22(9):810.e1-810.e8
pubmed: 26706615
Curr Infect Dis Rep. 2007 Nov;9(6):435-40
pubmed: 17999877
J Cell Sci. 2009 Jan 15;122(Pt 2):159-63
pubmed: 19118207
Clin Infect Dis. 2005 Sep 1;41(5):634-53
pubmed: 16080086
Lancet Infect Dis. 2019 Dec;19(12):e405-e421
pubmed: 31699664
J Clin Microbiol. 2018 Sep 25;56(10):
pubmed: 30068535
Mol Cell Proteomics. 2006 Jan;5(1):79-96
pubmed: 16195222

Auteurs

Abdullah Alqarihi (A)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.

Teclegiorgis Gebremariam (T)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.

Yiyou Gu (Y)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.

Marc Swidergall (M)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

Sondus Alkhazraji (S)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.

Sameh S M Soliman (SSM)

Research Institute for Medical and Health Sciences, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.

Vincent M Bruno (VM)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.

John E Edwards (JE)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

Scott G Filler (SG)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

Priya Uppuluri (P)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

Ashraf S Ibrahim (AS)

Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA ibrahim@lundquist.org.
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH